Novak Djokovic has a majority stake in a Danish biotechnology firm attempting to develop a treatment for Covid-19, the London Independent has reported.
Djokovic is now back in Serbia after being deported from Australia on Sunday for failing to meet the country’s tough Covid immigration laws.
QuantBioRes boss Ivan Loncarevic has revealed that the tennis player’s acquisition of an 80 per cent stake was made in June 2020.
The company is developing a peptide, which inhibits the virus from infecting the human cell, and expects to launch clinical trials later this year.
The CEO told the media organisation the company had about a dozen researchers working in Denmark, Australia and Slovenia.
Djokovic and his wife Jelena own 40.8 per cent and 39.2 per cent of the company, respectively.
Rafael Nadal lined up for what was to be the final match of his career…
Jannik Sinner took charge in front of his home crowd on Sunday, crushing ATP Finals…
Daniil Medvedev went into meltdown mode on Sunday during a highly charged 6-4, 6-3 loss, with opponent…
Jannik Sinner could well be missing from the opening European clay event of next season…
Rafael Nadal will bring down the curtain on his career next month as he plays his…
Wimbledon on Wednesday brought an end to human linecalling at the most traditional of the…